ENTITY
Scilex

Scilex (SCLX US)

12
Analysis
Health Care • United States
Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido® for postherpetic neuralgia, ELYXYB® for migraine, and GLOPERBA® for gout flares. The company is headquartered in Palo Alto, California, and was founded in 2019.
more
bullish•Scilex
•08 Aug 2026 23:43

Primer: Scilex (SCLX US) - Aug 2026

Scilex is a commercial-stage pharmaceutical company focused on non-opioid pain management, a sector poised for growth due to the ongoing opioid...

Logo
92 Views
Share
x